For many of us, the idea of addiction recovery and behavior change therapy might invoke images of a psychologist or counselor leading a one-on-one or group session, but these images probably wouldn’t involve the use of psychedelic drug therapy.

On today’s episode, Associate Professor of Psychiatry and Behavioral Sciences at Johns Hopkins and author of 47 articles on psychedelic drugs, Matthew Johnson, PhD, discusses how psychedelic drugs such as psilocybin pills can help people who face addiction, depression, and emotional or psychological disorders.

“It’s not just a drug effect; it’s something about the nature of this experience, the qualitative nature of the experience that’s predictive of long-term beneficial outcomes…even though it’s prompted by a medication…in many ways it’s more like a learning experience. It has more in common with what we know about…psychotherapy than it does with psychiatric medications,” says Dr. Johnson.

On today’s episode, you will learn:

• How Dr. Johnson characterizes the commonality between people who benefit from the use of psychedelics (and it’s not about religion or spirituality)
• How psychedelic drug use with psilocybin could help those who suffer addiction to cocaine, alcohol, or tobacco, as well as cancer-related depression, anorexia, and PTSD
• When psilocybin pills could become an FDA-approved option for clinical treatment of a variety of disorders

Press play for all the details.

Podcast: Play in new window | Download | Embed